BR112022019434A2 - Peptídeo que tem atividade de mobilização de células-tronco mesenquimais - Google Patents

Peptídeo que tem atividade de mobilização de células-tronco mesenquimais

Info

Publication number
BR112022019434A2
BR112022019434A2 BR112022019434A BR112022019434A BR112022019434A2 BR 112022019434 A2 BR112022019434 A2 BR 112022019434A2 BR 112022019434 A BR112022019434 A BR 112022019434A BR 112022019434 A BR112022019434 A BR 112022019434A BR 112022019434 A2 BR112022019434 A2 BR 112022019434A2
Authority
BR
Brazil
Prior art keywords
peptide
mesenchymal stem
stem cell
cell mobilization
activity
Prior art date
Application number
BR112022019434A
Other languages
English (en)
Portuguese (pt)
Inventor
Tamai Katsuto
Shimbo Takashi
Yamazaki Takehiko
Original Assignee
Stemrim Inc
Univ Osaka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemrim Inc, Univ Osaka filed Critical Stemrim Inc
Publication of BR112022019434A2 publication Critical patent/BR112022019434A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112022019434A 2020-04-03 2021-04-02 Peptídeo que tem atividade de mobilização de células-tronco mesenquimais BR112022019434A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020067570 2020-04-03
PCT/JP2021/014253 WO2021201260A1 (ja) 2020-04-03 2021-04-02 間葉系幹細胞の動員活性を有するペプチド

Publications (1)

Publication Number Publication Date
BR112022019434A2 true BR112022019434A2 (pt) 2022-12-06

Family

ID=77929177

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022019434A BR112022019434A2 (pt) 2020-04-03 2021-04-02 Peptídeo que tem atividade de mobilização de células-tronco mesenquimais

Country Status (8)

Country Link
US (1) US20230241159A1 (https=)
EP (1) EP4144359A4 (https=)
JP (1) JP7672636B2 (https=)
CN (1) CN115697372A (https=)
BR (1) BR112022019434A2 (https=)
CA (1) CA3178719A1 (https=)
IL (1) IL296982B2 (https=)
WO (1) WO2021201260A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3556378B1 (en) 2017-01-27 2025-03-12 StemRIM Inc. Therapeutic agent for cardiomyopathy, old myocardial infarction and chronic heart failure
US20210024594A1 (en) 2018-02-08 2021-01-28 StemRIM Inc. Therapeutic Agent for Psoriasis
US12304933B2 (en) 2018-10-05 2025-05-20 StemRIM Inc. Disease treatment drug based on mesenchymal-stem-cell mobilization

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8673580B2 (en) 2008-04-30 2014-03-18 Genomix Co., Ltd. Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
JP5865703B2 (ja) * 2009-10-28 2016-02-17 株式会社ジェノミックス 骨髄間葉系および／または多能性幹細胞の血中動員による組織再生促進剤
PT3358011T (pt) * 2011-04-26 2020-04-23 Univ Osaka Péptido para induzir a regeneração de um tecido e a sua utilização
US20200038486A1 (en) * 2017-04-07 2020-02-06 StemRIM Inc. Therapeutic medicine for fibrous disease
CA3059544A1 (en) * 2017-04-25 2018-11-01 Shionogi & Co., Ltd. Peptide for inducing regeneration of tissue, and use thereof
CN111542335A (zh) * 2017-12-01 2020-08-14 斯特姆里姆有限公司 炎症性肠病的治疗药
WO2020071520A1 (ja) * 2018-10-05 2020-04-09 株式会社ステムリム 間葉系幹細胞の動員活性を有するペプチド
WO2020158924A1 (ja) * 2019-01-31 2020-08-06 国立大学法人大阪大学 母児間免疫寛容を誘導する方法

Also Published As

Publication number Publication date
CA3178719A1 (en) 2021-10-07
JP7672636B2 (ja) 2025-05-08
CN115697372A (zh) 2023-02-03
JPWO2021201260A1 (https=) 2021-10-07
US20230241159A1 (en) 2023-08-03
IL296982B1 (en) 2025-12-01
IL296982A (en) 2022-12-01
WO2021201260A1 (ja) 2021-10-07
EP4144359A1 (en) 2023-03-08
EP4144359A4 (en) 2024-05-01
IL296982B2 (en) 2026-04-01

Similar Documents

Publication Publication Date Title
BR112022019434A2 (pt) Peptídeo que tem atividade de mobilização de células-tronco mesenquimais
Ilan Microtubules: From understanding their dynamics to using them as potential therapeutic targets
Aguilar et al. Genetic basis of cell–cell fusion mechanisms
CY1121447T1 (el) Συνθεσεις για αυξηση δραστηριοτητας τελομερασης
CY1118073T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
Gould et al. Mood stabilizer psychopharmacology
AR079114A1 (es) Proteinas de enlace de antigenos anti-orai1 y usos de las mismas
CY1112241T1 (el) Θραυσματα πεπτιδιου για διεγερση συνθεσης πρωτεϊνων εξωκυτταρικης μητρας
RU2010148785A (ru) Фармацевтическое средство для стимуляции функциональной регенерации поврежденной ткани
BR0010496A (pt) Regulação da expressão genica viral
RU2013126581A (ru) Мутанты стрептокиназы и их ковалентно модифицированные формы
CY1116164T1 (el) Προδρομη 4-σουλφαταση ν-ακετυλογαλακτο σαμινης, μεθοδοι θεραπευτικης αγωγης που χρησιμοποιουν το εν λογω ενζυμο και μεθοδοι για παραγωγη και καθαρισμο του εν λογω ενζυμου
Wang et al. Priming integrin alpha 5 promotes the osteogenic differentiation of human periodontal ligament stem cells due to cytoskeleton and cell cycle changes
BR112023019951A2 (pt) Linhagens hematopoiéticas derivadas de células-tronco pluripotentes
AU2011340430A1 (en) Immune restricted peptides with increased efficacy
Matsumura et al. Mid-Holocene hunter-gatherers ‘Gaomiao’in Hunan, China: the first of the two-layer model in the population history of East/Southeast Asia
Árnason et al. The reversal of human phylogeny: Homo left Africa as erectus, came back as sapiens sapiens
Oren‐Suissa et al. Evolution of programmed cell fusion: common mechanisms and distinct functions
BRPI0416434A (pt) métodos para aumentar a atividade de uma proteìna de ácido esfingomielinase (asm), para estender a meia-vida e prolongar a atividade de uma proteìna asm purificada, para aumentar a produção de uma proteìna asm recombinante através de uma célula hospedeira, e usos de uma composição de asm tipo alelo-selvagem, purificada e um composto análogo de ceramida ou esfingomielina, e de um composto análogo de ceramida ou de esfingomielina
ES2639573T3 (es) Péptidos que tienen afinidad de unión por un anticuerpo que reconoce un epítopo en un bucle 2 de alfa 1 o bucle 1 de beta 2 de un receptor adrenérgico
BRPI0515893B8 (pt) peptídeos da proteína humana de estresse térmico, composição farmacêutica, e, uso do peptídeo e da composição farmacêutica.
Zhang et al. Effects of equibiaxial mechanical stretch on extracellular matrix‐related gene expression in human calvarial osteoblasts
CN102807609A (zh) 一种预防和/或治疗疼痛的多肽及其应用
CN113527462B (zh) 一种具有镇痛作用的小分子肽及其特异性抗体
CN110041404B (zh) 瓜氨酸化抗原修饰肽及其应用